Patricia Njuguna
Patricia Njuguna
Verified email at
Cited by
Cited by
Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised …
S Rts
Lancet 386 (9988), 31-45, 2015
Efficacy of RTS, S/AS01E vaccine against malaria in children 5 to 17 months of age
P Bejon, J Lusingu, A Olotu, A Leach, M Lievens, J Vekemans, S Mshamu, ...
New England Journal of Medicine 359 (24), 2521-2532, 2008
Phase 1 trials of rVSV Ebola vaccine in Africa and Europe
ST Agnandji, A Huttner, ME Zinser, P Njuguna, C Dahlke, JF Fernandes, ...
New England Journal of Medicine 374 (17), 1647-1660, 2016
Seven-year efficacy of RTS, S/AS01 malaria vaccine among young African children
A Olotu, G Fegan, J Wambua, G Nyangweso, A Leach, M Lievens, ...
New England Journal of Medicine 374 (26), 2519-2529, 2016
Genetic diversity and protective efficacy of the RTS, S/AS01 malaria vaccine
DE Neafsey, M Juraska, T Bedford, D Benkeser, C Valim, A Griggs, ...
New England Journal of Medicine 373 (21), 2025-2037, 2015
Four-year efficacy of RTS, S/AS01E and its interaction with malaria exposure
A Olotu, G Fegan, J Wambua, G Nyangweso, KO Awuondo, A Leach, ...
New England Journal of Medicine 368 (12), 1111-1120, 2013
Efficacy and safety of the RTS, S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites
RTS, S Clinical Trials Partnership (2014)
PLoS medicine 11 (7), e1001685, 2014
Immunogenicity of the RTS, S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial
MT White, R Verity, JT Griffin, KP Asante, S Owusu-Agyei, B Greenwood, ...
The Lancet infectious diseases 15 (12), 1450-1458, 2015
Efficacy of RTS, S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5–17 months in Kenya and Tanzania: a …
A Olotu, J Lusingu, A Leach, M Lievens, J Vekemans, S Msham, T Lang, ...
The Lancet infectious diseases 11 (2), 102-109, 2011
Risk and causes of paediatric hospital-acquired bacteraemia in Kilifi District Hospital, Kenya: a prospective cohort study
AM Aiken, N Mturi, P Njuguna, S Mohammed, JA Berkley, I Mwangi, ...
The Lancet 378 (9808), 2021-2027, 2011
Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults
C Ogwang, D Kimani, NJ Edwards, R Roberts, J Mwacharo, G Bowyer, ...
Science translational medicine 7 (286), 286re5-286re5, 2015
Prevalence and risk factors of neurological disability and impairment in children living in rural Kenya
V Mung'ala-Odera, R Meehan, P Njuguna, N Mturi, KJ Alcock, C Newton
International journal of epidemiology 35 (3), 683-688, 2006
Prevalence, incidence and risk factors of epilepsy in older children in rural Kenya
V Mung’ala-Odera, S White, R Meehan, GO Otieno, P Njuguna, N Mturi, ...
Seizure 17 (5), 396-404, 2008
Systems vaccinology identifies an early innate immune signature as a correlate of antibody responses to the Ebola vaccine rVSV-ZEBOV
A Rechtien, L Richert, H Lorenzo, G Martrus, B Hejblum, C Dahlke, ...
Cell reports 20 (9), 2251-2261, 2017
Excess child mortality after discharge from hospital in Kilifi, Kenya: a retrospective cohort analysis
JC Moïsi, H Gatakaa, JA Berkley, K Maitland, N Mturi, CR Newton, ...
Bulletin of the World Health Organization 89 (10), 725-732, 2011
Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered …
SH Hodgson, E Juma, A Salim, C Magiri, D Kimani, D Njenga, A Muia, ...
Frontiers in microbiology 5, 686, 2014
Validity and reliability of the ‘Ten Questions’ questionnaire for detecting moderate to severe neurological impairment in children aged 6–9 years in rural Kenya
V Mung’ala-Odera, R Meehan, P Njuguna, N Mturi, K Alcock, JA Carter, ...
Neuroepidemiology 23 (1-2), 67-72, 2004
A phase 2a randomized study to evaluate the safety and immunogenicity of the 1790GAHB generalized modules for membrane antigen vaccine against Shigella sonnei administered …
CW Obiero, AGW Ndiaye, AS Sciré, BM Kaunyangi, E Marchetti, AM Gone, ...
Frontiers in immunology 8, 1884, 2017
Effect of the Pre-erythrocytic Candidate Malaria Vaccine RTS,S/AS01E on Blood Stage Immunity in Young Children
P Bejon, J Cook, E Bergmann-Leitner, A Olotu, J Lusingu, J Mwacharo, ...
Journal of Infectious Diseases 204 (1), 9-18, 2011
Age, spatial, and temporal variations in hospital admissions with malaria in Kilifi County, Kenya: a 25-year longitudinal observational study
P Mogeni, TN Williams, G Fegan, C Nyundo, E Bauni, K Mwai, I Omedo, ...
PLoS medicine 13 (6), e1002047, 2016
The system can't perform the operation now. Try again later.
Articles 1–20